
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding the landscape of E3 ligases for targeted protein degradation
Luke T. Kramer, Xiaoyu Zhang
Current Research in Chemical Biology (2022) Vol. 2, pp. 100020-100020
Open Access | Times Cited: 46
Luke T. Kramer, Xiaoyu Zhang
Current Research in Chemical Biology (2022) Vol. 2, pp. 100020-100020
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Small-molecule discovery through DNA-encoded libraries
Alexander A. Peterson, David R. Liu
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 699-722
Closed Access | Times Cited: 82
Alexander A. Peterson, David R. Liu
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 699-722
Closed Access | Times Cited: 82
Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders
Alexander Hanzl, Ryan Casement, Hana Imrichová, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 3, pp. 323-333
Open Access | Times Cited: 73
Alexander Hanzl, Ryan Casement, Hana Imrichová, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 3, pp. 323-333
Open Access | Times Cited: 73
From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
Vladas Oleinikovas, Pablo Gaínza, Thomas Ryckmans, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 291-312
Open Access | Times Cited: 51
Vladas Oleinikovas, Pablo Gaínza, Thomas Ryckmans, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 291-312
Open Access | Times Cited: 51
Delivering on the promise of protein degraders
Matthew N. O’Brien, Suman Luthra, Matthew F. Brown, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 410-427
Closed Access | Times Cited: 50
Matthew N. O’Brien, Suman Luthra, Matthew F. Brown, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 410-427
Closed Access | Times Cited: 50
PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer
Kailee A. Rutherford, Kirk J. McManus
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 4, pp. 454-463
Open Access | Times Cited: 15
Kailee A. Rutherford, Kirk J. McManus
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 4, pp. 454-463
Open Access | Times Cited: 15
Recruitment of FBXO22 for targeted degradation of NSD2
Yan Nie, John R. Tabor, Jianping Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1597-1607
Closed Access | Times Cited: 13
Yan Nie, John R. Tabor, Jianping Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1597-1607
Closed Access | Times Cited: 13
The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation
Tomasz Sobierajski, Joanna Małolepsza, Marta Pichlak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104032-104032
Open Access | Times Cited: 9
Tomasz Sobierajski, Joanna Małolepsza, Marta Pichlak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104032-104032
Open Access | Times Cited: 9
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation
Chrysanthi Kagiou, José A. Cisneros, Jakob Farnung, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Chrysanthi Kagiou, José A. Cisneros, Jakob Farnung, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
A Mechanistic Pharmacodynamic Modeling Framework for the Assessment and Optimization of Proteolysis Targeting Chimeras (PROTACs)
Robin Thomas Ulrich Haid, Andreas Reichel
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 195-195
Open Access | Times Cited: 17
Robin Thomas Ulrich Haid, Andreas Reichel
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 195-195
Open Access | Times Cited: 17
Advancements in PROTAC-based therapies for neurodegenerative diseases
Deyuan Kong, Liying Meng, Pengfei Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Deyuan Kong, Liying Meng, Pengfei Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
Qi Huang, Linghao Hu, Hao Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Qi Huang, Linghao Hu, Hao Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
Renyu Guo, Fukang Yang, Emily C. Cherney
RSC Medicinal Chemistry (2025)
Closed Access
Renyu Guo, Fukang Yang, Emily C. Cherney
RSC Medicinal Chemistry (2025)
Closed Access
Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access
Single amino acid–based PROTACs trigger degradation of the oncogenic kinase BCR–ABL in chronic myeloid leukemia (CML)
Jianchao Zhang, Caibing Ma, Yongjun Yu, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104994-104994
Open Access | Times Cited: 12
Jianchao Zhang, Caibing Ma, Yongjun Yu, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104994-104994
Open Access | Times Cited: 12
Native Mass Spectrometry of Complexes Formed by Molecular Glues Reveals Stoichiometric Rearrangement of E3 Ligases
Cara Jackson, Rebecca Beveridge
The Analyst (2024) Vol. 149, Iss. 11, pp. 3178-3185
Open Access | Times Cited: 3
Cara Jackson, Rebecca Beveridge
The Analyst (2024) Vol. 149, Iss. 11, pp. 3178-3185
Open Access | Times Cited: 3
Targeted protein degradation in mammalian cells: A promising avenue toward future
Tianyi Zhang, Chuanyang Liu, Wenying Li, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5477-5489
Open Access | Times Cited: 16
Tianyi Zhang, Chuanyang Liu, Wenying Li, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5477-5489
Open Access | Times Cited: 16
Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15
Targeted Protein Degradation: Clinical Advances in the Field of Oncology
Abdelrahman K. A. A. Salama, Marija V. Trkulja, Emilio Casanova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15440-15440
Open Access | Times Cited: 15
Abdelrahman K. A. A. Salama, Marija V. Trkulja, Emilio Casanova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15440-15440
Open Access | Times Cited: 15
Small-Molecule Approaches to Target Transcription Factors
Huarui Cui, Morgan Stilgenbauer, Angela N. Koehler
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 395-415
Closed Access | Times Cited: 2
Huarui Cui, Morgan Stilgenbauer, Angela N. Koehler
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 395-415
Closed Access | Times Cited: 2
Application of A lphaF old models in evaluating ligandable cysteines across E 3 ligases
Patrick Koldenhof, Martijn P. Bemelmans, B.K. Ghosh, et al.
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 7, pp. 819-829
Closed Access | Times Cited: 2
Patrick Koldenhof, Martijn P. Bemelmans, B.K. Ghosh, et al.
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 7, pp. 819-829
Closed Access | Times Cited: 2
Pooled endogenous protein tagging and recruitment for systematic profiling of protein function
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
Cell Genomics (2024), pp. 100651-100651
Open Access | Times Cited: 2
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
Cell Genomics (2024), pp. 100651-100651
Open Access | Times Cited: 2
The new direction of drug development: Degradation of undruggable targets through targeting chimera technology
Xuewu Liang, Hairu Ren, Fengyang Han, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 632-685
Closed Access | Times Cited: 6
Xuewu Liang, Hairu Ren, Fengyang Han, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 632-685
Closed Access | Times Cited: 6
Native Mass Spectrometry of Complexes Formed by Molecular Glues Reveals Stoichiometric Rearrangement of E3 Ligases
Cara Jackson, Rebecca Beveridge
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Cara Jackson, Rebecca Beveridge
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Selection of DNA-encoded Chemical Libraries for Compounds that can Induce Protein Ubiquitination
Cen Huang, Xing‐Yuan Liu, Xinyuan Wu, et al.
(2024)
Open Access | Times Cited: 1
Cen Huang, Xing‐Yuan Liu, Xinyuan Wu, et al.
(2024)
Open Access | Times Cited: 1